Company intelligence / Profile preview

MedChemica

Alderley Edge / Macclesfield area, England, United Kingdommedchemica.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

MedChemica has contributed to the development of at least nine candidate drugs with clients using its data-driven medicinal chemistry expertise. The company’s technology has enabled the creation of the largest documented database of medicinal chemistry ADMET knowledge and accelerated multiple drug discovery programs across therapeutic areas. It played a key role in supporting COVID Moonshot’s lead optimization/preclinical phase. No direct clinical trial results as it operates as a CRO/platform provider.

Therapeutic areas: OncologyEndocrinologyImmunologyInfectious Diseases
Modalities: Small moleculeData-driven drug design platform/software
Industry: Drug Discovery Services

Partnerships

COVID Moonshot consortium/DNDi partnership for anti-infective researchNovartisTakedaUCB

Beyond the preview

Go deeper on MedChemica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedChemica.

Explore the full profile